BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25354046)

  • 1. Androgen insensitivity syndrome.
    Tadokoro-Cuccaro R; Hughes IA
    Curr Opin Endocrinol Diabetes Obes; 2014 Dec; 21(6):499-503. PubMed ID: 25354046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen insensitivity syndrome.
    Mongan NP; Tadokoro-Cuccaro R; Bunch T; Hughes IA
    Best Pract Res Clin Endocrinol Metab; 2015 Aug; 29(4):569-80. PubMed ID: 26303084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertoli cell tumor and intratubular germ cell neoplasia located in separate gonads in an adolescent patient with complete androgen insensitivity: a case report and review of literature.
    Lin MH; Shamszadeh M; Pitukcheewanont P
    J Pediatr Endocrinol Metab; 2012; 25(5-6):547-51. PubMed ID: 22876554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of gonadal tumours in complete androgen insensitivity syndrome (CAIS): A retrospective case-series analysis.
    Chaudhry S; Tadokoro-Cuccaro R; Hannema SE; Acerini CL; Hughes IA
    J Pediatr Urol; 2017 Oct; 13(5):498.e1-498.e6. PubMed ID: 28351649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.
    Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Androgen insensitivity syndrome. Clinical features and molecular genetics].
    Sólyom J; Scheiber D; Fekete G
    Orv Hetil; 2001 Aug; 142(31):1659-65. PubMed ID: 11556259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome.
    Cheikhelard A; Morel Y; Thibaud E; Lortat-Jacob S; Jaubert F; Polak M; Nihoul-Fekete C
    J Urol; 2008 Oct; 180(4):1496-501. PubMed ID: 18710728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Gonads in Adults with Androgen Insensitivity: An International Survey.
    Tack LJW; Maris E; Looijenga LHJ; Hannema SE; Audi L; Köhler B; Holterhus PM; Riedl S; Wisniewski A; Flück CE; Davies JH; T'Sjoen G; Lucas-Herald AK; Evliyaoglu O; Krone N; Iotova V; Marginean O; Balsamo A; Verkauskas G; Weintrob N; Ellaithi M; Nordenström A; Verrijn Stuart A; Kluivers KB; Wolffenbuttel KP; Ahmed SF; Cools M
    Horm Res Paediatr; 2018; 90(4):236-246. PubMed ID: 30336477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant testicular germ cell tumors in postpubertal individuals with androgen insensitivity: prevalence, pathology and relevance of single nucleotide polymorphism-based susceptibility profiling.
    Cools M; Wolffenbuttel KP; Hersmus R; Mendonca BB; Kaprová J; Drop SLS; Stoop H; Gillis AJM; Oosterhuis JW; Costa EMF; Domenice S; Nishi MY; Wunsch L; Quigley CA; T'Sjoen G; Looijenga LHJ
    Hum Reprod; 2017 Dec; 32(12):2561-2573. PubMed ID: 29121256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen insensitivity syndrome.
    Mendoza N; Motos MA
    Gynecol Endocrinol; 2013 Jan; 29(1):1-5. PubMed ID: 22812659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis.
    Wünsch L; Holterhus PM; Wessel L; Hiort O
    BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence.
    Huang H; Wang C; Tian Q
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):621-627. PubMed ID: 27862157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity.
    Akcay T; Fernandez-Cancio M; Turan S; Güran T; Audi L; Bereket A
    Andrology; 2014 Jul; 2(4):572-8. PubMed ID: 24737579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Deletion of thymine at position 2298 in exon 5 of the androgenic receptor gene causing complete androgen insensitivity syndrome].
    Soriano Guillén L; Muñoz Calvo MT; Martinez Pérez J; Pozo Román J; Martín Sobrino MA; González Medeiro I; Argente Oliver J
    An Esp Pediatr; 2002 Apr; 56(4):347-52. PubMed ID: 11927080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen insensitivity syndrome.
    Hughes IA; Werner R; Bunch T; Hiort O
    Semin Reprod Med; 2012 Oct; 30(5):432-42. PubMed ID: 23044881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Insensitivity Syndrome: Management Considerations from Infancy to Adulthood.
    Chen MJ; Vu BM; Axelrad M; Dietrich JE; Gargollo P; Gunn S; Macias CG; McCullough LB; Roth DR; Sutton VR; Karaviti LP
    Pediatr Endocrinol Rev; 2015 Jun; 12(4):373-87. PubMed ID: 26182482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome.
    Deeb A; Mason C; Lee YS; Hughes IA
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):56-62. PubMed ID: 15963062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic diagnosis and genetic counseling for androgen-insensitivity syndrome: a report of three cases.
    Yamaguchi M; Sameshima H; Ikenoue T
    J Obstet Gynaecol Res; 2014 Mar; 40(3):723-7. PubMed ID: 24321103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Management Protocol for Gonad Preservation in Patients with Androgen Insensitivity Syndrome.
    Weidler EM; Linnaus ME; Baratz AB; Goncalves LF; Bailey S; Hernandez SJ; Gomez-Lobo V; van Leeuwen K
    J Pediatr Adolesc Gynecol; 2019 Dec; 32(6):605-611. PubMed ID: 31233832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.